Status:
UNKNOWN
Continuous Versus Discontinuous Design of Encircling Lesions During Ablation for Atrial Fibrillation
Lead Sponsor:
Institute for Clinical and Experimental Medicine
Collaborating Sponsors:
Charles University, Czech Republic
3rd Department of Internal Medicine - Cardiology
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Acute efficacy of point-by-point radiofrequency ablation for pulmonary vein isolation in patients with atrial fibrillation are comparable independantly of the ablation strategy (continous versus disco...
Detailed Description
The number of pulmonary vein isolation (PVI) therapy for atrial fibrillation (AF) is increasing. Durable PVI is cornerstone for long-term freedom of AF. In one previous study continuous ablation was s...
Eligibility Criteria
Inclusion
- Patients undergoing pulmonary vein isolation with radiofrequency catheter ablation for paroxysmal atrial fibrillation treatment.
Exclusion
- \-
Key Trial Info
Start Date :
September 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03332862
Start Date
September 15 2017
End Date
January 31 2018
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Clinical and Experimental Medicine
Prague, Czechia